Abstract:Background: MicroRNAs are noncoding RNAs and have emerged as important regulators in β-cell function. Results: miR-483 is highly expressed in β-cells but expressed at much lower levels in α-cells, and increased miR-483 induces insulin production in β-cells while repressing glucagon production in α-cells. Conclusion: miR-483 has opposite effects in α- and β-cells by targeting SOCS3. Significance: miR-483 is a potential therapeutic target for diabetes. Insulin secreted from pancreatic β-cells and glucagon secreted from pancreatic α-cells are the two major hormones working in the pancreas in an opposing manner to regulate and maintain a normal glucose homeostasis. How microRNAs (miRNAs), a population of non-coding RNAs so far demonstrated to be differentially expressed in various types of cells, regulate gene expression in pancreatic β-cells and its closely associated α-cells is not completely clear. In this study, miRNA profiling was performed and compared between pancreatic β-cells and their partner α-cells. One novel miRNA, miR-483, was identified for its highly differential expression in pancreatic β-cells when compared to its expression in α-cells. Overexpression of miR-483 in β-cells increased insulin transcription and secretion by targeting SOCS3, a member of suppressor of cytokine signaling family. In contrast, overexpression of miR-483 decreased glucagon transcription and secretion in α-cells. Moreover, overexpressed miR-483 protected against proinflammatory cytokine-induced apoptosis in β-cells. This correlates with a higher expression level of miR-483 and the expanded β-cell mass observed in the islets of prediabetic db/db mice. Together, our data suggest that miR-483 has opposite effects in α- and β-cells by targeting SOCS3, and the imbalance of miR-483 and its targets may play a crucial role in diabetes pathogenesis.

MicroRNA-17-92 Cluster Regulates Pancreatic Beta-Cell Proliferation and Adaptation.

MicroRNA-223 is Essential for Maintaining Functional Β-Cell Mass During Diabetes Through Inhibiting Both FOXO1 and SOX6 Pathways

MiR-221/222 inhibit insulin production of pancreatic β-cells in mice.

Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2.

Loss of miR-23b/27b/24-1 Cluster Impairs Glucose Tolerance via Glycolysis Pathway in Mice

Mir-192 Is Upregulated In T1dm, Regulates Pancreatic -Cell Development And Inhibits Insulin Secretion Through Suppressing Glp-1 Expression

MicroRNA-127 inhibits cell proliferation via targeting Kif3b in pancreatic β cells

miR-375 maintains normal pancreatic α- and β-cell mass

MicroRNA-26a Regulates Insulin Sensitivity and Metabolism of Glucose and Lipids.

Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic Β- and Α-Cells

MiR-17-5p Inhibits TXNIP/NLRP3 Inflammasome Pathway and Suppresses Pancreatic β-Cell Pyroptosis in Diabetic Mice

Abstract 19722: Cardiac Deletion of miRNA-17-92 Cluster Augments Acute Myocardial Ischemia-Reperfusion Injury

Insulin Secretory Granules Release Exosomal miR-503 to Promote Insulin Resistance and β-Cell Senescence

MicroRNA 152 Regulates Hepatic Glycogenesis by Targeting PTEN.

mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts.

MiR-17-5p Enhances Pancreatic Cancer Proliferation by Altering Cell Cycle Profiles Via Disruption of RBL2/E2F4-repressing Complexes.

Expression of miRNA-29 in Pancreatic β Cells Promotes Inflammation and Diabetes via TRAF3

MicroRNA Networks in Pancreatic Islet Cells: Normal Function and Type 2 Diabetes

A pancreatic islet-specific microRNA regulates insulin secretion

MiR-190 ameliorates glucotoxicity-induced dysfunction and apoptosis of pancreatic β-cells by inhibiting NOX2-mediated reactive oxygen species production

Microrna-20a-5p Contributes to Hepatic Glycogen Synthesis Through Targeting P63 to Regulate P53 and Pten Expression